Petr Šmejkal

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic

Peter Salaj, Petr Brabec, Miroslav Penka et al. · Haemophilia · 2009 · 70 citations

Pharmacotherapy, Thrombosis, Translational Medicine +18

Influence of 3D models and animations on students in natural subjects

Milada Teplá, Pavel Teplý, Petr Šmejkal · International Journal of STEM Education · 2022 · 56 citations · Full text

Intrinsic Motivation Inventory, Science Education, Educational Psychology +25

A comparative analysis of different automated von Willebrand factor glycoprotein Ib‐binding activity assays in well typed von Willebrand disease patients

Inge Vangenechten, Katarzina Mayger, Petr Šmejkal et al. · Journal of Thrombosis and Haemostasis · 2018 · 35 citations · Full text

Autoimmune Disease, Medicine, Hematology +3

To ventilate or not to ventilate during bystander CPR — A EuReCa TWO analysis

Jan Wnent, Ingvild Tjelmeland, Rolf Lefering et al. · Resuscitation · 2021 · 30 citations · Full text

Cardiopulmonary Resuscitation, Emergency Medicine Injury, Bystander Cpr +9

FEIBA^®in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre

Petr Šmejkal, Petr Brabec, Miloslava Matýšková et al. · Haemophilia · 2009 · 17 citations